{"transactions":[{"id":739892,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38753,"kind":"person","name":"PERLMAN ANDREW J","position":1,"cik":"0001201617","reported_name":"PERLMAN ANDREW J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T20:27:48.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":16900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control."}],"balance_after":16900,"derivative":{"exercise_price":23.3,"expiration_date":"2036-06-10","underlying":"Stock Option (Rights to Buy)","underlying_shares":16900},"source":{"system":"sec-edgar","filing":"0001201617-26-000003","document":"wk-form4_1781296065.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000120161726000003/wk-form4_1781296065.xml","form_type":"4"}},{"id":739891,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38753,"kind":"person","name":"PERLMAN ANDREW J","position":1,"cik":"0001201617","reported_name":"PERLMAN ANDREW J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T20:27:48.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":5700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control."}],"balance_after":48325,"source":{"system":"sec-edgar","filing":"0001201617-26-000003","document":"wk-form4_1781296065.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000120161726000003/wk-form4_1781296065.xml","form_type":"4"}},{"id":1113513,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38753,"kind":"person","name":"PERLMAN ANDREW J","position":1,"cik":"0001201617","reported_name":"PERLMAN ANDREW J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T20:29:10.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":38300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control."}],"balance_after":38300,"derivative":{"exercise_price":10.02,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":38300},"source":{"system":"sec-edgar","filing":"0001724521-25-000092","document":"wk-form4_1749760139.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000172452125000092/wk-form4_1749760139.xml","form_type":"4"}},{"id":1113512,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38753,"kind":"person","name":"PERLMAN ANDREW J","position":1,"cik":"0001201617","reported_name":"PERLMAN ANDREW J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T20:29:10.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":13300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control."}],"balance_after":42625,"source":{"system":"sec-edgar","filing":"0001724521-25-000092","document":"wk-form4_1749760139.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000172452125000092/wk-form4_1749760139.xml","form_type":"4"}},{"id":1486871,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38753,"kind":"person","name":"PERLMAN ANDREW J","position":1,"cik":"0001201617","reported_name":"PERLMAN ANDREW J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T22:20:21.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in full on the earlier of June 6, 2025 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control."}],"balance_after":24000,"derivative":{"exercise_price":15.9,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001724521-24-000112","document":"wk-form4_1717798812.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000172452124000112/wk-form4_1717798812.xml","form_type":"4"}},{"id":1486870,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38753,"kind":"person","name":"PERLMAN ANDREW J","position":1,"cik":"0001201617","reported_name":"PERLMAN ANDREW J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T22:20:21.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":8400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in full on the earlier of June 6, 2025 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control."}],"balance_after":29325,"source":{"system":"sec-edgar","filing":"0001724521-24-000112","document":"wk-form4_1717798812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000172452124000112/wk-form4_1717798812.xml","form_type":"4"}},{"id":1852385,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38753,"kind":"person","name":"PERLMAN ANDREW J","position":1,"cik":"0001201617","reported_name":"PERLMAN ANDREW J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-17T00:09:56.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in full on the earlier of June 15, 2024 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control."}],"balance_after":19500,"derivative":{"exercise_price":19.6,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001209191-23-038148","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000120919123038148/doc4.xml","form_type":"4"}},{"id":1852384,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38753,"kind":"person","name":"PERLMAN ANDREW J","position":1,"cik":"0001201617","reported_name":"PERLMAN ANDREW J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-17T00:09:56.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":6800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in full on the earlier of June 15, 2024 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control."}],"balance_after":20925,"source":{"system":"sec-edgar","filing":"0001209191-23-038148","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000120919123038148/doc4.xml","form_type":"4"}},{"id":2230011,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38753,"kind":"person","name":"PERLMAN ANDREW J","position":1,"cik":"0001201617","reported_name":"PERLMAN ANDREW J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-16T20:34:03.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":16800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option will vest in full on the earlier of June 14, 2023 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control."}],"balance_after":16800,"derivative":{"exercise_price":20.62,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":16800},"source":{"system":"sec-edgar","filing":"0001209191-22-037438","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000120919122037438/doc4.xml","form_type":"4"}},{"id":2230010,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38753,"kind":"person","name":"PERLMAN ANDREW J","position":1,"cik":"0001201617","reported_name":"PERLMAN ANDREW J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-16T20:34:03.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in full on the earlier of June 14, 2023 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,500 and 3,000 shares of restricted stock units (previously reported) that vested on December 15, 2021 and June 3, 2022, respectively."}],"balance_after":11125,"source":{"system":"sec-edgar","filing":"0001209191-22-037438","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000120919122037438/doc4.xml","form_type":"4"}},{"id":2679415,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38753,"kind":"person","name":"PERLMAN ANDREW J","position":1,"cik":"0001201617","reported_name":"PERLMAN ANDREW J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-07T20:42:19.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":14100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in full on the earlier of (i) 12 months following the date of grant or (ii) the date of the next annual stockholder meeting following the grant. The option becomes fully vested and exercisable in the event the Company is subject to a change in control."}],"balance_after":14100,"derivative":{"exercise_price":24.79,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":14100},"source":{"system":"sec-edgar","filing":"0001209191-21-038635","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000120919121038635/doc4.xml","form_type":"4"}},{"id":2679414,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38753,"kind":"person","name":"PERLMAN ANDREW J","position":1,"cik":"0001201617","reported_name":"PERLMAN ANDREW J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-07T20:42:19.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest 100% on the earlier of June 3, 2022 or the next annual meeting of the stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control."}],"balance_after":5525,"source":{"system":"sec-edgar","filing":"0001209191-21-038635","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000120919121038635/doc4.xml","form_type":"4"}},{"id":2938066,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38753,"kind":"person","name":"PERLMAN ANDREW J","position":1,"cik":"0001201617","reported_name":"PERLMAN ANDREW J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-19T00:58:53.000Z","date":"2020-12-17","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is exercisable in 36 equal monthly installments after December 17, 2020, subject to the Reporting Person's continued service to the Company."}],"balance_after":21000,"derivative":{"exercise_price":31.77,"expiration_date":"2030-12-16","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-20-064561","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000120919120064561/doc4.xml","form_type":"4"}},{"id":2938065,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38753,"kind":"person","name":"PERLMAN ANDREW J","position":1,"cik":"0001201617","reported_name":"PERLMAN ANDREW J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-19T00:58:53.000Z","date":"2020-12-17","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in three equal annual installments on each of December 15, 2021, December 15, 2022 and December 15, 2023, subject to the Reporting Person's continued service to the Company."}],"balance_after":4500,"source":{"system":"sec-edgar","filing":"0001209191-20-064561","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000120919120064561/doc4.xml","form_type":"4"}}]}